Hobert succeeds Kerpelman as head of Kodak’s Health Group

Article

Kodak’s Health Group has a new head. On Feb.16, the company appointed Kevin J. Hobert president of the group and senior vice president of Eastman Kodak. He will report to Antonio M. Perez, Kodak’s president and COO.

Kodak's Health Group has a new head. On Feb.16, the company appointed Kevin J. Hobert president of the group and senior vice president of Eastman Kodak. He will report to Antonio M. Perez, Kodak's president and COO.

Hobert replaces Daniel Kerpelman, who is leaving the company to become CEO

of SGS Group, a publicly traded European firm. Kerpelman will assume his new duties April 11. SGS Group, founded in 1878, runs about 1000 offices and laboratories around the world specializing in inspection, verification, testing, and certification. Services are provided to a number of industries, including diagnostics.

Hobert previously served as general manager of Kodak's Digital Capture Systems and vice president of its Health Group. Under Hobert, Kodak's computed radiography business has attained the number two position worldwide, according to the company. Hobert also recently ushered Kodak's mammography CAD system through the FDA approval process.

Hobert joined Kodak in 2002 from GE Medical Systems, after 11 years in medical imaging. He was responsible for leading GEMS' global businesses addressing digital, analog and mobile radiography and multipurpose fluoroscopy. Hobert holds a bachelor of science in physics from the University of Wisconsin.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.